CD8A and breast cancer: Silencing miR-21 significantly reduces the proliferation of Tregs in vitro and, as shown by the adoptive cell-transfer assay, alters the enrichment of Tregs in the tumor, thus improving the antitumor effect of CD8(+) T-cells in a murine BC model.